{
    "Trade/Device Name(s)": [
        "CareSens N Premier Blood Glucose Monitoring System",
        "CareSens N Premier BT Blood Glucose Monitoring System",
        "CareSens N Single Blood Glucose Test Strips",
        "CareSens Glucose Control Solution"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K170614",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160742"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "September 18, 2017",
    "Summary Letter Received Date": "September 19, 2017",
    "Submission Date": "February 24, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens N Premier Blood Glucose Meter",
        "CareSens N Premier BT Blood Glucose Meter",
        "Lancing device"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric method"
    ],
    "Methodologies": [
        "Electrochemical glucose detection"
    ],
    "Submission Type(s)": [
        "Monitoring System",
        "Test Strips",
        "Control Solution",
        "Meter",
        "Lancing device"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens N Premier and CareSens N Premier BT blood glucose monitoring systems for self-testing using electrochemical biosensor technology.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the fingertip, for self-testing by individuals with diabetes at home as an aid to monitor diabetes control; not for neonatal use or for diagnosis/screening of diabetes.",
    "fda_folder": "Clinical Chemistry"
}